학술논문

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Document Type
Article
Source
In: Clinical Genitourinary Cancer. (Clinical Genitourinary Cancer, June 2023, 21(3):366-375)
Subject
Language
English
ISSN
19380682
15587673